Task: Answer the multiple-choice question.
Query: Which drug exhibits a -15.542% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CC(C#CCN1CCCCC1)OCCOCc1ccccc1.Cl
(b) Cc1ccc(C)c(S(=O)(=O)N2CCCC2CNC(=O)C(=O)NCC2CCCO2)c1
Answer: b. Cc1ccc(C)c(S(=O)(=O)N2CCCC2CNC(=O)C(=O)NCC2CCCO2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C)c(S(=O)(=O)N2CCCC2CNC(=O)C(=O)NCC2CCCO2)c1
Cc1ccc(C)c(S(=O)(=O)N2CCCC2CNC(=O)C(=O)NCC2CCCO2)c1
N-[[1-(2,5-dimethylphenyl)sulfonylpyrrolidin-2-yl]methyl]-N'-(oxolan-2-ylmethyl)oxamide